Literature DB >> 10330430

Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy.

J Mogensen1, I C Klausen, A K Pedersen, H Egeblad, P Bross, T A Kruse, N Gregersen, P S Hansen, U Baandrup, A D Borglum.   

Abstract

We identified the alpha-cardiac actin gene (ACTC) as a novel disease gene in a pedigree suffering from familial hypertrophic cardiomyopathy (FHC). Linkage analyses excluded all the previously reported FHC loci as possible disease loci in the family studied, with lod scores varying between -2.5 and -6.0. Further linkage analyses of plausible candidate genes highly expressed in the adult human heart identified ACTC as the most likely disease gene, showing a maximal lod score of 3.6. Mutation analysis of ACTC revealed an Ala295Ser mutation in exon 5 close to 2 missense mutations recently described to cause the inherited form of idiopathic dilated cardiomyopathy (IDC). ACTC is the first sarcomeric gene described in which mutations are responsible for 2 different cardiomyopathies. We hypothesize that ACTC mutations affecting sarcomere contraction lead to FHC and that mutations affecting force transmission from the sarcomere to the surrounding syncytium lead to IDC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330430      PMCID: PMC408458          DOI: 10.1172/JCI6460

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Binding sites involved in the interaction of actin with the N-terminal region of dystrophin.

Authors:  B A Levine; A J Moir; V B Patchell; S V Perry
Journal:  FEBS Lett       Date:  1992-02-17       Impact factor: 4.124

2.  Atomic structure of the actin:DNase I complex.

Authors:  W Kabsch; H G Mannherz; D Suck; E F Pai; K C Holmes
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

3.  Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing adult hearts.

Authors:  K R Boheler; L Carrier; D de la Bastie; P D Allen; M Komajda; J J Mercadier; K Schwartz
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 4.  Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction.

Authors:  A S Zot; J D Potter
Journal:  Annu Rev Biophys Biophys Chem       Date:  1987

5.  Quantitation of aortic regurgitation by colour coded cross-sectional Doppler echocardiography.

Authors:  H Baumgartner; H Kratzer; G Helmreich; P Kühn
Journal:  Eur Heart J       Date:  1988-04       Impact factor: 29.983

6.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

7.  Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families.

Authors:  K Schwartz; J Beckmann; C Dufour; L Faure; F Fougerousse; L Carrier; C Hengstenberg; D Cohen; H P Vosberg; A Sacrez
Journal:  Circ Res       Date:  1992-07       Impact factor: 17.367

8.  Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.

Authors:  K Sandvej; S C Peh; B S Andresen; G Pallesen
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

9.  Structure of the actin-myosin complex and its implications for muscle contraction.

Authors:  I Rayment; H M Holden; M Whittaker; C B Yohn; M Lorenz; K C Holmes; R A Milligan
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

10.  Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.

Authors:  C A MacRae; N Ghaisas; S Kass; S Donnelly; C T Basson; H C Watkins; R Anan; L H Thierfelder; K McGarry; E Rowland
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more
  90 in total

1.  Toward an understanding of the cause of mitral valve prolapse.

Authors:  J A Towbin
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

Review 2.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 3.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

Review 4.  Modifier genes for hypertrophic cardiomyopathy.

Authors:  A J Marian
Journal:  Curr Opin Cardiol       Date:  2002-05       Impact factor: 2.161

5.  Complexity in simplicity: monogenic disorders and complex cardiomyopathies.

Authors:  J Chen; K R Chien
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

Review 6.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

7.  Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies.

Authors:  Kenneth R Chien
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  Functional characterization of the human α-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy.

Authors:  Mirco Müller; Antonina Joanna Mazur; Elmar Behrmann; Ralph P Diensthuber; Michael B Radke; Zheng Qu; Christoph Littwitz; Stefan Raunser; Cora-Ann Schoenenberger; Dietmar J Manstein; Hans Georg Mannherz
Journal:  Cell Mol Life Sci       Date:  2012-05-29       Impact factor: 9.261

Review 9.  Mechanical and energetic consequences of HCM-causing mutations.

Authors:  Cecilia Ferrantini; Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Corrado Poggesi
Journal:  J Cardiovasc Transl Res       Date:  2009-10-09       Impact factor: 4.132

Review 10.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.